“…Although more than half (24/45, 53%) of the AI applications had no action autonomy [ 46 , 48 - 51 , 53 , 54 , 57 , 63 , 66 , 67 , 70 , 73 - 75 , 79 , 81 - 85 , 87 - 89 ], a few reported applications had low (2/21, 10%) [ 55 , 72 ], medium (4/21, 19%) [ 58 , 69 , 71 , 86 ], or high (6/21, 29%) [ 52 , 55 , 60 , 61 , 68 , 76 ] action autonomy ( Table 2 , Multimedia Appendices 2 and 3 ). Nearly three-quarters of all AI systems were intended for clinical care (33/45, 73%) [ 46 , 49 , 51 , 53 - 59 , 61 , 63 - 73 , 78 - 80 , 84 - 89 ], and the majority (18/33, 55%) of these concerned providing support to inform the patient-provider encounter [ 46 , 49 , 51 , 55 , 56 , 61 , 63 , 65 , 67 , 68 , 74 , 78 , 79 , 84 , 85 , 87 , 89 ], followed by diagnosis and prediction-based diagnosis (13/33, 39%) [ …”